Skip to Main Content

Here you can browse the complete list of publications for studies listed on CDAS.

Studies
Publication Year
Results: 1067 (Showing 1 to 20)
Title PubMed Id Authors Journal Abbreviation Year Studies
Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction. 33398198 Conti DV, Darst BF, Moss LC, Saunders EJ, Sheng X, Chou A, Schumacher FR, Olama AAA, Benlloch S, Dadaev T, Brook MN, Sahimi A, Hoffmann TJ, Takahashi A, Matsuda K, Momozawa Y, Fujita M, Muir K, Lophatananon A, Wan P, Le Marchand L, Wilkens LR, Steve… Nat Genet 2021 PLCO
Genetic variants in the cholesterol biosynthesis pathway genes and risk of prostate cancer. 33444688 Cheng Y, Meng Y, Li S, Cao D, Ben S, Qin C, Hua L, Cheng G Gene 2021 PLCO
Selenium Kinetics in Humans Change Following 2 years of Supplementation with Selenomethionine Patterson BH, Combs GF Jr., Taylor PR, Patterson KY, Moler JE, Wastney ME Front Endocrinol (Lausanne) 2021 Selenium
Circulating adipokine concentrations and risk of five obesity-related cancers: A Mendelian randomization study. 33038280 Dimou NL, Papadimitriou N, Mariosa D, Johansson M, Brennan P, Peters U, Chanock SJ, Purdue M, Bishop DT, Gago-Dominquez M, Giles GG, Moreno V, Platz EA, Tangen CM, Wolk A, Zheng W, Wu X, Campbell PT, Giovannucci E, Lin Y, CCFR, Endometrial Cancer As… Int J Cancer 2021 PLCO
Smoking modifies pancreatic cancer risk loci on 2q21.3. 33574088 Mocci E, Kundu P, Wheeler W, Arslan AA, Beane Freeman LE, Bracci PM, Brennan P, Canzian F, Du M, Gallinger S, Giles GG, Goodman PJ, Kooperberg C, Le Marchand L, Neale RE, Shu XO, Visvanathan K, White E, Zheng W, Albanes D, Andreotti G, Babic A, Baml… Cancer Res 2021 PLCO
A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer. 33517887 López de Maturana E, Rodríguez JA, Alonso L, Lao O, Molina-Montes E, Martín-Antoniano IA, Gómez-Rubio P, Lawlor R, Carrato A, Hidalgo M, Iglesias M, Molero X, Löhr M, Michalski C, Perea J, O'Rorke M, Barberà VM, Tardón A, Farré A, Muñoz-Bellvís L, C… Genome Med 2021 PLCO
Combining pulmonary and cardiac computed tomography biomarkers for disease-specific risk modelling in lung cancer screening. 33574075 Schreuder A, Jacobs C, Lessmann N, Broeders MJ, Silva M, Išgum I, de Jong PA, Sverzellati N, Prokop M, Pastorino U, Schaefer-Prokop CM, van Ginneken B Eur Respir J 2021 NLST
Clinical Significance of Lung-RADS Category 3 lesions in the National Lung Screening Trial. 33722708 Han DH, Duan F, Wu Y, Goo JM, Kim HY, Patz EF J Thorac Oncol 2021 NLST
Glycemic Index, Glycemic Load, and Risk of Ovarian Cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cohort. 33693724 Mongiovi JM, Freudenheim JL, Moysich KB, McCann SE J Nutr 2021 PLCO
A phase II randomized placebo-controlled trial of pomegranate fruit extract in men with localized prostate cancer undergoing active surveillance. 33095939 Jarrard D, Filon M, Huang W, Havighurst T, DeShong K, Kim K, Konety BR, Saltzstein D, Mukhtar H, Wollmer B, Suen C, House MG, Parnes HL, Bailey HH Prostate 2021 EPPT
Local Transdermal Delivery of Telapristone Acetate Through Breast Skin, Compared With Oral Treatment: A Randomized Double-Blind, Placebo-Controlled Phase II Trial. 32996592 Lee O, Pilewskie M, Karlan S, Tull MB, Benante K, Xu Y, Blanco L, Helenowski I, Kocherginsky M, Yadav S, Hosseini O, Hansen N, Bethke K, Muzzio M, Troester MA, Dimond E, Perloff M, Heckman-Stoddard B, Khan SA Clin Pharmacol Ther 2021 EPPT
Aspirin, ibuprofen, and reduced risk of advanced colorectal adenoma incidence and recurrence and colorectal cancer in the PLCO Cancer Screening Trial. 33974712 Chudy-Onwugaje K, Huang WY, Su LJ, Purdue MP, Johnson CC, Wang L, Katki HA, Barry KH, Berndt SI Cancer 2021 PLCO
Deep Learning for Malignancy Risk Estimation of Pulmonary Nodules Detected at Low-Dose Screening CT. 34003056 Venkadesh KV, Setio AAA, Schreuder A, Scholten ET, Chung K, W Wille MM, Saghir Z, van Ginneken B, Prokop M, Jacobs C Radiology 2021 NLST
Inhibition of mTOR signaling and clinical activity of metformin in oral premalignant lesions. 34255745 Gutkind JS, Molinolo A, Wu X, Wang Z, Nachmanson D, Harismendy O, Alexandrov LB, Wuertz BR, Ondrey FG, Laronde DM, Rock LD, Rosin MP, Coffey CS, Butler VD, Bengtson L, Hsu CH, Bauman JE, Hewitt SM, Cohen EE, Chow HHS, Lippman SM, Szabo E JCI Insight 2021 EPPT
Dietary phytoestrogen intake and lung cancer risk: an analysis of the Prostate, Lung, Colorectal, and Ovarian (PLCO) cancer screening trial. 34370838 Wang Q, Ru M, Zhang Y, Kurbanova T, Boffetta P Carcinogenesis 2021 PLCO
Association of the Age at Menarche with Site-Specific Cancer Risks in Pooled Data from Nine Cohorts. 33820799 Fuhrman BJ, Moore SC, Byrne C, Makhoul I, Kitahara CM, Berrington de González A, Linet MS, Weiderpass E, Adami HO, Freedman ND, Liao LM, Matthews CE, Stolzenberg-Solomon RZ, Gaudet MM, Patel AV, Lee IM, Buring JE, Wolk A, Larsson SC, Prizment AE, Ro… Cancer Res 2021 PLCO
Genetic variants of 34094683 Du H, Liu L, Liu H, Luo S, Patz EF, Glass C, Su L, Du M, Christiani DC, Wei Q Am J Cancer Res 2021 PLCO
Development and Validation of an Interpretable Artificial Intelligence Model to Predict 10-Year Prostate Cancer Mortality. 34205398 Bibault JE, Hancock S, Buyyounouski MK, Bagshaw H, Leppert JT, Liao JC, Xing L Cancers (Basel) 2021 PLCO
An investigation of cross-sectional associations of a priori-selected dietary components with circulating bile acids. 34477829 Byrd DA, Sinha R, Weinstein SJ, Albanes D, Freedman ND, Sampson J, Loftfield E Am J Clin Nutr 2021 PLCO
Associations between metabolites and pancreatic cancer risk in a large prospective epidemiological study. 32060129 Stolzenberg-Solomon R, Derkach A, Moore S, Weinstein SJ, Albanes D, Sampson J Gut 2020 PLCO